42 studies found for:    CARD14
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults
Condition: Bacillus Anthracis (Anthrax) Infection
Interventions: Biological: BioThrax;   Biological: AV7909 Formulation 1;   Biological: AV7909 Formulation 2;   Biological: AV7909 Formulation 3;   Biological: AV7909 Formulation 4;   Drug: Control
2 Terminated
Has Results
Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: AZD0328;   Drug: Placebo
3 Completed
Has Results
A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy
Conditions: Excessive Daytime Sleepiness;   Narcolepsy
Interventions: Drug: Placebo;   Drug: PF-03654746
4 Completed CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events
Conditions: Major Coronary Event;   Cerebrovascular Accident;   Coronary Artery Bypass Graft;   Angina, Unstable;   Revascularization
Intervention: Drug: Atorvastatin
5 Completed
Has Results
Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults
Condition: Anthrax
Intervention: Biological: BioThrax
6 Completed Polio NID and Routine EPI Integration Trial Pakistan
Condition: Polio
Interventions: Behavioral: Vaccine promotion messages;   Other: Vaccination Verification.;   Other: Distribution of Plastic Pouches to retain vaccination card
7 Completed beCLomethasone Efficacy in Acute Rhinosinusitis - CLEAR Study
Condition: Acute Rhinosinusitis
Interventions: Drug: beclomethasone dipropionate 800 mcg/2 ml suspension for nebulization,one administration b.i.d. for 14 days;   Drug: placebo 2 ml suspension for nebulization, one administration b.i.d. for 14 days
8 Recruiting Efficacy and Safety of Lanreotide 120 Milligram (mg) as a Palliative Treatment of Clinical Symptoms Associated With Malignant Intestinal Obstruction in Inoperable Patients
Condition: Malignant Intestinal Obstruction
Intervention: Drug: Lanreotide (acetate)
9 Completed Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills
Conditions: Schizophenia Disorder;   Schizoaffective Disorder
Intervention: Drug: aripiprazole
10 Not yet recruiting Generalized Neonatal Screening of Severe Combined Immunodeficiencies
Condition: Severe Combined Immunodeficiency, Atypical
Intervention: Biological: SCID screening
11 Completed
Has Results
Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: armodafinil;   Drug: placebo
12 Completed IndiaCLEN Multicentre Trial of Home Versus Hospital Oral Amoxicillin for Management of Severe Pneumonia in Children
Condition: Pneumonia
Intervention: Other: Severe Pneumonia - Home Management
13 Completed The Effect of Picricum Acidum and Phosphoricum Acidum Homaccord on Perceived Levels of Anxiety in University Students
Condition: Anxiety
Interventions: Other: Sucrose pillules;   Other: Homeopathic homaccord
14 Recruiting Evaluation of Changes in Skin Carotenoid Scores in Medical Students Following Dietary Interventions
Condition: Health Behavior
Intervention: Other: Food-based intervention; increased fruits and vegetables
15 Completed
Has Results
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention: Biological: Oral, live, pentavalent rotavirus vaccine; RotaTeq(R)
16 Completed Budesonide / Formoterol in Treatment of Exacerbations of COPD
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: budesonide/formoterol, 2x 200/6 microgram. 4 times daily;   Drug: prednisolone, 30 mg once daily and placebo
17 Completed A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer
Conditions: Neoplasms;   Breast Cancer
Intervention: Biological: Immunotherapeutic SB719125 (Primary)
18 Recruiting A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069/P06200)
Condition: Fungal Infections
Interventions: Drug: Posaconazole;   Drug: Voriconazole
19 Completed Antiretroviral Drug Interaction Study in Volunteers With HIV
Conditions: HIV;   PCP;   Toxoplasmosis
Interventions: Drug: Atovaquone 750 mg twice daily;   Drug: Atovaquone 1500 mg twice daily
20 Active, not recruiting A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline
Condition: Smoking Cessation
Interventions: Behavioral: Telephone counseling;   Drug: Nicotine patches;   Behavioral: Incentive

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years